If you are not happy with the results below please do another search
“Compliancy Group is the first of a cadre of HIPAA compliance resources vetted by the CHC to assist agencies working with healthcare covered entities to navigate the nuances of HIPAA, federal breach notification requirements, and evolving state privacy laws,” said Jim Potter, CHC executive director.
Peregrine Market Access, a full-service consulting, communications, and commercialization partner for the life sciences industry, announced the hiring of Mawais Farooqui as a data analyst and Lewis “Lewi” Clarke as an associate account executive.
Generic drugs present a notable absence of consensus among physicians within the realm of healthcare regarding patients’ choice between branded and generic alternatives. This lack of a clear stance among healthcare providers prompts an in-depth investigation into the myriad factors shaping their perspectives, including efficacy, patient preferences, and cost considerations.
Bayer continued its leadership shuffle not only at its world headquarters in Germany but at two U.S.–based subsidiaries. Yet most of the executive movement of late has been at smaller companies.
At this week’s American Academy of Neurology annual meeting, Amylyx provided additional data from its Phase III amyotrophic lateral sclerosis study showing the full extent of Relyvrio’s failure.
The trial results add to a growing body of clinical evidence that suggests GLP-1 drugs, which include popular treatments such as Lilly’s Mounjaro and Novo Nordisk’s Wegovy, have medical benefits beyond diabetes and weight loss.
Sage Therapeutics said it will stop development of its experimental drug to treat Parkinson’s disease after the treatment failed a mid-stage study, sending the company’s shares tumbling 36% before the bell.
Today the drugmaker said long-term data showed that its blockbuster shingles vaccine, Shingrix, had 79.7% efficacy in participants aged 50 years and above, six to 11 years after vaccination.
Pharmacy benefit managers (PBMs) are in the crosshairs of Republicans and Democrats in Congress but have so far dodged any new litigation or reforms that had been targeted for inclusion in last month’s U.S. government budget deal.
Med Ad News sat down with Ankit Vahia, Ph.D., who recently joined ConcentricLife as chief strategy officer, to talk about the agency’s strategy behind delivering experiences versus having a transactional relationship with clients and brands.